Sign in
4

Changes in Ownership

DiaMedica Therapeutics Inc. Filed Acc 0001235802-24-000015

Options or other derivatives

  • Chief Medical Officer acquired 285,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lorianne Masuoka K. Chief Medical Officer 2024-01-22 Grant or award · Stock option (right to buy) +285,000 285,000 D
Loading xslF345X05/primary_doc.xml…